Seventh Framework Programme for Research and Technological Development

Seventh Framework Programme for Research and Technological Development. Commonly known as FP7, it was the European Union's main instrument for funding scientific research and technological development from 2007 to 2013. With a budget exceeding €50 billion, it aimed to strengthen the scientific and technological base of European industry and foster its international competitiveness. The programme was a cornerstone of the Lisbon Strategy and a key driver for completing the European Research Area.

Overview and objectives

FP7 was established by a decision of the European Parliament and the Council of the European Union to consolidate the European Union's role as a world leader in specific scientific research domains. Its overarching goals were to support the creation of a European Research Area of world-class excellence and to stimulate economic growth and job creation across the member states of the European Union. The programme sought to enhance cooperation between universities, research institutes, and industries both within Europe and internationally. Key thematic priorities included advancing information and communication technologies, fostering breakthroughs in healthcare and nanotechnology, and addressing major societal challenges like climate change and energy security.

Structure and specific programmes

The architecture of FP7 was organized into four primary specific programmes, each with distinct mandates. The "Cooperation" programme promoted collaborative research across borders in ten thematic areas, including health, transport, and security. The "Ideas" programme, managed by the European Research Council, funded pioneering frontier research by individual teams led by top researchers. The "People" programme, also known as Marie Skłodowska-Curie Actions, supported the training, mobility, and career development of researchers. Finally, the "Capacities" programme aimed to strengthen research capacities by funding research infrastructure, support for small and medium-sized enterprises, and activities in regions of Europe.

Budget and funding mechanisms

With a total budget of €50.5 billion for the seven-year period, FP7 represented a significant increase over its predecessor, the Sixth Framework Programme. Funding was allocated through competitive calls for proposals, evaluated by independent experts based on criteria of scientific excellence, impact, and implementation. The primary funding instruments included collaborative projects, networks of excellence, and coordination and support actions. A substantial portion of the budget was directed through the European Research Council and the Joint Research Centre, with additional funds earmarked for the European Institute of Innovation and Technology and participation in joint undertakings like the Innovative Medicines Initiative.

Implementation and management

The overall implementation and strategic direction of FP7 were the responsibility of the European Commission, specifically the Directorate-General for Research and Innovation. Day-to-day management of calls and projects was handled by the Executive Agency for Small and Medium-sized Enterprises and various other dedicated executive agencies. The programme operated under rules for participation and dissemination set by the Council of the European Union, ensuring a coherent framework across all member states of the European Union. Monitoring and strategic input were provided by advisory groups such as the European Research Area Board and programme committees composed of representatives from national governments.

Key achievements and impact

FP7 funded over 25,000 projects, involving more than 100,000 participants from across Europe and partner countries. It enabled major scientific breakthroughs, including advancements at CERN and the Human Brain Project, and supported the careers of thousands of researchers through the Marie Skłodowska-Curie Actions. The programme significantly boosted the competitiveness of European industry, particularly in sectors like aerospace through the Clean Sky Joint Undertaking and pharmaceuticals via the Innovative Medicines Initiative. Its legacy in structuring the European research landscape directly informed the design and ambitious budget of its successor, Horizon 2020.

Category:European Union research programmes Category:2007 in science Category:2013 in science